PubRank

Dietmar Schmidt

Author PubWeight™ 23.28‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 2002 2.73
2 In vivo electrophysiological effects of a selective slow delayed-rectifier potassium channel blocker in anesthetized dogs: potential insights into class III actions. Cardiovasc Res 2004 1.55
3 Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma. Am J Pathol 2003 1.51
4 Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 Dual-stained cytology. Gynecol Oncol 2011 1.38
5 Screening for cervical cancer precursors with p16/Ki-67 dual-stained cytology: results of the PALMS study. J Natl Cancer Inst 2013 1.38
6 Conjunctive p16INK4a testing significantly increases accuracy in diagnosing high-grade cervical intraepithelial neoplasia. Am J Clin Pathol 2010 1.34
7 Survival benefit for patients with advanced-stage transitional cell carcinomas vs. other subtypes of ovarian carcinoma after chemotherapy with platinum and paclitaxel. Gynecol Oncol 2005 1.25
8 Immunostaining for p16INK4a used as a conjunctive tool improves interobserver agreement of the histologic diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 2008 1.01
9 Biomarkers for cervical cancer screening: the role of p16(INK4a) to highlight transforming HPV infections. Expert Rev Proteomics 2012 0.99
10 History of gynecological pathology. XV. Dr. Carl Arnold Ruge. Int J Gynecol Pathol 2004 0.98
11 Incurred sample reproducibility: views and recommendations by the European Bioanalysis Forum. Bioanalysis 2009 0.95
12 Evaluation of cervical cone biopsies for coexpression of p16INK4a and Ki-67 in epithelial cells. Int J Cancer 2011 0.94
13 p16 methylation does not affect protein expression in cervical carcinogenesis. Eur J Cancer 2008 0.92
14 Smad4 deficiency in cervical carcinoma cells. Oncogene 2005 0.91
15 Specialized pathology review in patients with ovarian cancer: results from a prospective study. Int J Gynecol Cancer 2013 0.91
16 Mammalian-specific OR37 receptors are differentially activated by distinct odorous fatty aldehydes. Chem Senses 2012 0.85
17 Histological grading in a large series of advanced stage ovarian carcinomas by three widely used grading systems: consistent lack of prognostic significance. A translational research subprotocol of a prospective randomized phase III study (AGO-OVAR 3 protocol). Virchows Arch 2009 0.80
18 Chemotherapy may be more effective in highly proliferative ovarian carcinomas--a translational research subprotocol of a prospective randomized phase III study (AGO-OVAR 3 protocol). Gynecol Oncol 2006 0.80
19 A current perspective on the pathological assessment of FOXL2 in adult-type granulosa cell tumours of the ovary. Histopathology 2013 0.80
20 No metastatic cervical adenocarcinomas in a series of p16INK4a-positive mucinous or endometrioid advanced ovarian carcinomas: an analysis of the AGO Ovarian Cancer Study Group. Int J Gynecol Pathol 2008 0.79
21 Molecular analysis of endometrial hyperplasia in HNPCC-suspicious patients may predict progression to endometrial carcinoma. Int J Gynecol Pathol 2004 0.77
22 Prolonged blood glucose reduction in mrp-2 deficient rats (GY/TR(-)) by the glucose-6-phosphate translocase inhibitor S 3025. Biochim Biophys Acta 2002 0.76
23 Double C-H activation: the palladium-catalyzed direct C-arylation of xanthines with arenes. Org Lett 2011 0.76
24 Distinction between endometrial and endocervical adenocarcinoma. Int J Gynecol Pathol 2002 0.75
25 Cu(I)-catalyzed domino reactions: efficient and selective synthesis of 4H-chromenes and naphthalenes. Org Lett 2011 0.75
26 [Cervical carcinoma. Current aspects of diagnosis and therapy]. Pathologe 2005 0.75
27 Combination of enzyme- and Lewis acid-catalyzed reactions: a new method for the synthesis of 6,7-dihydrobenzofuran-4(5H)-ones starting from 2,5-dimethylfuran and 1,3-cyclohexanediones. Org Biomol Chem 2013 0.75